4
Changes in Ownership
UroGen Pharma Ltd. Filed Acc 0001209191-20-005200
Chief Medical Officer sold 322 shares at $29.15 ($9,386)
- Chief Medical Officer acquired 833 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Schoenberg Mark · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-01-26 | Exercise or conversion : show line 1 in the form | +833 | 9,499 | D | ||
| 2020-01-27 | Sale : show line 2 in the form | −322 | $29.15 | $9,386 | 9,177 | D |
| Open-market sales · 322 sh · avg $29.15 · $9,386 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2020-01-26 | Exercise or conversion : show line 3 in the form Restricted Stock Units (RSUs) | −833 | 833 | 1,667 | D |
Loading xslF345X03/doc4.xml…